valproic acid has been researched along with apicidin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, MK; Jeong, JW; Jung, BK; Kim, KW; Kim, SH; Lee, JW; Park, JA; Seo, JH | 1 |
Doyon, G; Fyne, E; Huber, K; Mellors, JW; Plaks, J; Sluis-Cremer, N | 1 |
Abe, W; Kawano, Y; Li, H; Narahara, H; Nasu, K; Takai, N; Tsuno, A | 1 |
An, L; Jaime-Frias, R; Kadiyala, V; Mathieu, W; Patrick, NM; Pookhao, N; Smith, CL | 1 |
Beck, JF; Becker, S; Krämer, OH; Marx, C; Palani, CD; Sonnemann, J; Wittig, S | 1 |
Aleksunes, LM; Mosaad, F; Richardson, JR; Shin, HM; You, D | 1 |
6 other study(ies) available for valproic acid and apicidin
Article | Year |
---|---|
Regulation of the HIF-1alpha stability by histone deacetylases.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Enzyme Inhibitors; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoprecipitation; Mice; Peptides, Cyclic; Reverse Transcriptase Polymerase Chain Reaction; Transcriptional Activation; Valproic Acid | 2007 |
Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.
Topics: Adult; Histone Deacetylase Inhibitors; Histone Deacetylases; HIV Long Terminal Repeat; HIV-1; Humans; Hydroxamic Acids; Jurkat Cells; Peptides, Cyclic; Phosphatidylinositol 3-Kinases; Protein Isoforms; Proto-Oncogene Proteins c-akt; Signal Transduction; Substrate Specificity; Valproic Acid; Virus Activation; Virus Latency | 2011 |
Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target.
Topics: Acetylation; Adult; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Endometriosis; Epigenesis, Genetic; Female; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Peptides, Cyclic; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Valproic Acid; Vorinostat | 2011 |
Class I lysine deacetylases facilitate glucocorticoid-induced transcription.
Topics: Acetylation; Amidohydrolases; Animals; Cell Line, Tumor; Dexamethasone; Enzyme Inhibitors; Glucocorticoids; Histones; HSP90 Heat-Shock Proteins; Hydroxamic Acids; Lysine; Mice; Peptides, Cyclic; Protein Binding; Receptors, Glucocorticoid; Transcription, Genetic; Transcriptional Activation; Valproic Acid | 2013 |
p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors.
Topics: Benzamides; Cell Proliferation; Colonic Neoplasms; Flow Cytometry; Gene Expression Regulation, Neoplastic; HCT116 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Peptides, Cyclic; Proto-Oncogene Proteins c-mdm2; Pyridines; Tumor Suppressor Protein p53; Valproic Acid; Vorinostat | 2014 |
Brain region-specific regulation of histone acetylation and efflux transporters in mice.
Topics: Acetylation; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Brain; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Male; Mice; Peptides, Cyclic; Valproic Acid | 2019 |